From: An evaluation of the process of informed consent: views from research participants and staff
Where do you facilitate informed consent discussions? | Number of respondents (%), n = 115* |
Hospital | 99 (86%) |
University | 15 (13%) |
Primary Care/GP | 11 (10%) |
Telephone | 3 (3%) |
Community | 2 (2%) |
What kind of studies have you/do you work on? | Number of respondents (%), n = 115* |
CTIMPs | 83 (72%) |
Observational | 75 (65%) |
Translational/Biomarker/Biobanking | 63 (55%) |
Registry | 40 (35%) |
Non-CTIMPs intervention (e.g. surgery, radiation, psychology, physiotherapy, etc. intervention) | 45 (39%) |
Medical devices | 17 (15%) |
Nurse-led | 1 (0.9%) |
Feasibility studies | 1 (0.9%) |
Non-randomised study of a healthcare intervention | 1 (0.9%) |
Clinical trial of complex intervention (professional education/medication review) | 1 (0.9%) |
Qualitative studies | 1 (0.9%) |
How much experience do you have facilitating informed consent discussions with clinical research/trial participants? | Number of respondents (%), n = 115 |
<1 year | 10 (9%) |
1–2 years | 14 (12%) |
2–3 years | 9 (8%) |
3–5 years | 13 (11%) |
5+ years | 69 (60%) |
Have you ever received training on how to take informed consent from a research participant? | Number of respondents (%), n = 115 |
Yes | 74 (64%) |
No | 38 (33%) |
Didn’t reply | 3 (3%) |
If yes, was this: | n = 74* |
Formal/structured training | 45 (58%) |
Observation of a senior colleague | 41 (55%) |
Informal training | 39 (53%) |
Other | 5 (6.8%) |